Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia.

[1]  W. Evans,et al.  Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. , 1992, Blood.

[2]  K. Welte,et al.  Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. , 1992, Blood.

[3]  K. Shinohara,et al.  Fluctuations in serum cytokine levels in the patient with cyclic neutropenia , 1992, American journal of hematology.

[4]  K. Welte,et al.  Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. , 1991, Blood.

[5]  A. Migliaccio,et al.  Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony-stimulating factor in vivo. , 1990, Blood.

[6]  K. Welte,et al.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. , 1990, Blood.

[7]  Michael D. Green,et al.  GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION , 1989, The Lancet.

[8]  M. Green,et al.  Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  George Morstyn,et al.  Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor , 1989 .

[10]  J. Gabrilove,et al.  Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. , 1989, The New England journal of medicine.

[11]  D. Dale,et al.  Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. , 1989, The New England journal of medicine.

[12]  J. Gabrilove,et al.  Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. , 1989, The New England journal of medicine.

[13]  S. Nagata,et al.  A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders. , 1989, Experimental hematology.

[14]  S. Asano,et al.  Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. , 1989, Blood.

[15]  M. Green,et al.  EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY , 1988, The Lancet.

[16]  T. Chard,et al.  Pregnancy-specific beta-glycoprotein in complications of early pregnancy. , 1980, Lancet.

[17]  D. Rodbard,et al.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.